Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun study

Neurology

Volumn 58, Issue 10, 2002, Pages 1476-1482

  Gosche, K M ^a   Mortimer, J A ^a   Smith, C D ^a   Markesbery, W R ^a   Snowdon, D A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 0037188405     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.10.1476     Document Type: Article

References (46)

1. Neurofibrillary pathology-correlation with hippocampal formation atrophy in Alzheimer disease
2. Neuropathological staging of Alzheimer-related changes
3. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease
4. Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease
5. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
6. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
7. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
8. Alzheimer's disease: In vivo detection of differential vulnerability of brain regions
9. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease
10. Automatic detection of hippocampal atrophy on magnetic resonance images
11. Meta-analysis of regional brain volumes in schizophrenia
12. Hippocampal volume in patients with alcohol dependence
13. Hippocampal atrophy in normal aging. An association with recent memory impairment
14. Hippocampal formation size in normal human aging: A correlate of delayed secondary memory performance
15. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
16. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease
17. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
18. The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation
19. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study
20. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
21. Aging and Alzheimer's disease: Lessons from the Nun Study
22. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease
23. Simulated activities of daily living examination
24. The assessment of self-care capacity in geriatric psychiatric patients by objective and subjective methods
25. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery
26. Diagnosis of Alzheimer's disease
27. Automated quantification of brain magnetic resonance image hyperintensities using hybrid clustering and knowledge-based methods
28. An automated technique for measuring hippocampal volumes from MR imaging studies
29. Diagnostic tests 3: Receiver operating characteristic plots
30. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
31. Frequency of stages of Alzheimer-related lesions in different age categories
32. Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974
33. Mild cognitive impairment: Clinical characterization and outcome
34. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease
35. MRI of the hippocampus in Alzheimer's disease: Sensitivity, specificity, and analysis of the incorrectly classified subjects
36. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease
37. Validation of clinical diagnostic criteria for Alzheimer's disease
38. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques
39. Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease
40. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment
41. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type
42. Frequency of stages of Alzheimer-related lesions in different age categories
43. Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention
44. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
45. Mental status testing in the elderly nursing home population